-+ 0.00%
-+ 0.00%
-+ 0.00%

Silexion Therapeutics Announces Groundbreaking Preclinical Results for SIL204, Demonstrating Near-Complete Inhibition of Pan-KRAS Mutations Across Multiple Cancer Types

Reuters·09/30/2025 13:06:35

Please log in to view news